MEDITHYROX

UNIVADIS - MEDITHYROX /univadis/MEDITHYROX.md

ATC

Μορφές: TAB

Δραστικές

Δελτίο Τιμών 05/2018

Ημερομηνία barcode code περιεχομενο τιμή παραγωγός χονδρική λιανική
05/2018 2802660001018 266000101 MEDITHYROX TAB 25MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.31 1.37 1.89
05/2018 2802660001025 266000102 MEDITHYROX TAB 25MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.31 1.37 1.89
05/2018 2802660002015 266000201 MEDITHYROX TAB 50MC/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.32 1.38 1.90
05/2018 2802660002022 266000202 MEDITHYROX TAB 50MC/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.32 1.38 1.90
05/2018 2802660003012 266000301 MEDITHYROX TAB 75MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.33 1.39 1.92
05/2018 2802660003029 266000302 MEDITHYROX TAB 75MCG/TAB BTx30 (2 BLISTERS X15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.33 1.39 1.92
05/2018 2802660004019 266000401 MEDITHYROX TAB 88MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.33 1.39 1.92
05/2018 2802660004026 266000402 MEDITHYROX TAB 88MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.33 1.39 1.92
05/2018 2802660005016 266000501 MEDITHYROX TAB 100MC/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.33 1.40 1.93
05/2018 2802660005023 266000502 MEDITHYROX TAB 100MC/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.33 1.40 1.93
05/2018 2802660006013 266000601 MEDITHYROX TAB 112MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.34 1.41 1.94
05/2018 2802660006020 266000602 MEDITHYROX TAB 112MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.34 1.41 1.94
05/2018 2802660007010 266000701 MEDITHYROX TAB 125MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.35 1.42 1.96
05/2018 2802660007027 266000702 MEDITHYROX TAB 125MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.35 1.42 1.96
05/2018 2802660008017 266000801 MEDITHYROX TAB 137MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.35 1.42 1.96
05/2018 2802660008024 266000802 MEDITHYROX TAB 137MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.35 1.42 1.96
05/2018 2802660009014 266000901 MEDITHYROX TAB 150MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL) σε BLISTERS PVC/ALUM FOIL) 1.36 1.43 1.97
05/2018 2802660009021 266000902 MEDITHYROX TAB 150MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL) σε BLISTERS PVC/ALUM FOIL) 1.36 1.43 1.97
05/2018 2802660010010 266001001 MEDITHYROX TAB 175MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL) σε BLISTERS PVC/ALUM FOIL) 1.37 1.44 1.98
05/2018 2802660010027 266001002 MEDITHYROX TAB 175MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL) σε BLISTERS PVC/ALUM FOIL) 1.37 1.44 1.98
05/2018 2802660011017 266001101 MEDITHYROX TAB 200MC/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.38 1.45 2.00
05/2018 2802660011024 266001102 MEDITHYROX TAB 200MC/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.38 1.45 2.00
05/2018 2802660012014 266001201 MEDITHYROX TAB 12MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.30 1.36 1.88
05/2018 2802660012021 266001202 MEDITHYROX TAB 12MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.30 1.36 1.88
05/2018 2802660013011 266001301 MEDITHYROX TAB 62MCG/TAB BTx30 (BLIST 3x10) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.32 1.38 1.90
05/2018 2802660013028 266001302 MEDITHYROX TAB 62MCG/TAB BTx30 (2 BLISTERS x15) σε BLISTERS PVC/ALUM FOIL σε BLISTERS PVC/ALUM FOIL 1.32 1.38 1.90
  • DRUGBANK - Levothyroxine
  • indication:

    For use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor.

  • pharmacology:

  • mechanism:

    Levothyroxine acts like the endogenous thyroid hormone thyroxine (T<sub>4</sub>, a tetra-iodinated tyrosine derivative). In the liver and kidney, T<sub>4</sub> is converted to T<sub>3</sub>, the active metabolite. In order to increase solubility, the thyroid hormones attach to thyroid hormone binding proteins, thyroxin-binding globulin, and thyroxin-binding prealbumin (transthyretin). Transport and binding to thyroid hormone receptors in the cytoplasm and nucleus then takes place. Thus by acting as a replacement for natural thyroxine, symptoms of thyroxine deficiency are relieved.

  • toxicity:

    LD<sub>50</sub>=20 mg/kg (orally in rat). Hypermetabolic state indistinguishable from thyrotoxicosis of endogenous origin. Symptoms of thyrotoxicosis include weight loss, increased appetite, palpitations, nervousness, diarrhea, abdominal cramps, sweating, tachycardia, increased pulse and blood pressure, cardiac arrhythmias, tremors, insomnia, heat intolerance, fever, and menstrual irregularities.

  • absorprion:

    Bioavailability varies from 48% to 80%. Human studies have confirmed the importance of an intact jejunum and ileum for levothyroxine absorption and have shown some absorption from the duodenum.

  • halflife:

    T<sub>4</sub>, 6 to 7 days. T<sub>3</sub>, 1 to 2 days.

  • roouteelimination:

    Thyroid hormones are primarily eliminated by the kidneys.

  • volumedistribution:

  • clearance: